CompletedNCT02526212
Group Medical Visits for Buprenorphine Treatment in Primary Care
About this title
Read the official source — NCT02526212Medication studyAges 18+United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- The BronxSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateStarted: January 1, 2017
- Recruitment status
- Completed
- Enrollment listed in the registry
- 18
- Sponsor
- Montefiore Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Behavioral
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT02526212
- Official title
Show the full official title
Buprenorphine Group Medical Visits for Drug Users at Risk for HIV
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
The Bronx
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Montefiore Medical Center, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Buprenorphine.
Who was this study for?
Listed age limits: from 18 years.
